FDA inspection
ImprimisRx CA, Inc., dba ImprimisRx: FDA inspection ending Mar 31, 2017
FDA inspection 1010017 · Irvine, CA
Key facts
| Inspection ID | 1010017 |
|---|---|
| Firm | ImprimisRx CA, Inc., dba ImprimisRx |
| FEI number | 3003436217 |
| Address | 9257 Research Dr |
| City | Irvine |
| State | CA |
| ZIP | 92618-4286 |
| Fiscal year | 2017 |
| Inspection end date | Mar 31, 2017 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 541375 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data